H. Seki

Choto-san in the treatment of vascular dementia: a double-blind, placebo-controlled study.

G. Araki, K. Terasawa, S. Takase, 1997, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Cerebrospinal Fluid Tau Protein as a Potential Diagnostic Marker in Alzheimer’s Disease

J. Trojanowski, C. Clark, H. Arai, 1998, Neurobiology of Aging.

Clinical and laboratory features of myelitis patients with anti-neutrophil cytoplasmic antibodies

Y. Itoyama, K. Fujihara, N. Okita, 1998, Journal of the Neurological Sciences.

Subjective symptoms Heaviness of head Headache Dizziness of vertigo Shoulder stiffness Palpitation Distress feeling of chest Feeling of hot flushes Tinnitus Numbness of limbs Coldness of limbs General malaise Appetite loss Neurological symptoms Aphasia Dysarthria

S. Takase, S. Takaori, M. Fujioka, 2011 .

Intrathecal synthesis of immunosuppressive acidic protein (IAP) in patients with multiple sclerosis and other inflammatory neurological diseases

H. Aso, H. Seki, K. Tamura, 1988, Journal of the Neurological Sciences.

Significant increase in immunosuppressive acidic protein (IAP) in serum of patients with multiple sclerosis and other inflammatory neurological disorders

S. Takase, H. Seki, T. Tsukamoto, 1986, Journal of the Neurological Sciences.

Consensus report of the working group on: 'Molecular and biochemical markers of Alzheimer's disease'

Giovanni B. Frisoni, Alfredo Robles, Takeshi Iwatsubo, 1998 .

No increase in cerebrospinal fluid tau protein levels in patients with vascular dementia

H. Arai, M. Higuchi, Hidetada Sasaki, 1998, Neuroscience Letters.

Treatment of multiple sclerosis with anti-measles cow colostrum

S. Takase, H. Aso, N. Ishida, 2005, Medical Microbiology and Immunology.